Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors

Overview of attention for article published in Molecular Cancer, February 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 79 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 251 followers.

RT @OncoBioMed: Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment https://t.co/w3nyZ0ddoU #Saturd…

12 May 2018

Reply Repost Favourite

Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. https://t.co/s9pgOk5X3k

20 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.